(Q40928922)

24 September 2017

1 reference

title

Addiction: brain mechanisms and their treatment implications (English)

1 reference

24 September 2017

D J Nutt

1

1 reference

PubMed ID

8531549

24 September 2017

language of work or name

English

0 references

publication date

1 January 1996

1 reference

24 September 2017

6

1 reference

inferred from page(s)

published in

The Lancet

1 reference

24 September 2017

347

1 reference

24 September 2017

8993

1 reference

24 September 2017

31-36

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2896%2991561-5

24 September 2017

1 reference

7 January 2021

Pharmacologic effects and abuse liability of bretazenil, diazepam, and alprazolam in humans

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2896%2991561-5

7 January 2021

Naltrexone treatment of heroin addiction: one-year follow-up.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2896%2991561-5

7 January 2021

Selective antagonists of benzodiazepines

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2896%2991561-5

7 January 2021

Cloning and expression of a cocaine-sensitive dopamine transporter complementary DNA.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2896%2991561-5

7 January 2021

GBR12909 antagonizes the ability of cocaine to elevate extracellular levels of dopamine

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2896%2991561-5

7 January 2021

Cocaine addiction: psychology and neurophysiology

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2896%2991561-5

7 January 2021

Drugs abused by humans preferentially increase synaptic dopamine concentrations in the mesolimbic system of freely moving rats

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2896%2991561-5

7 January 2021

Effects of selective D1 and D2 dopamine antagonists on cocaine self-administration in the rat

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2896%2991561-5

7 January 2021

Dopamine transporter, alcoholism and other diseases

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2896%2991561-5

7 January 2021

Overexcitement and disinhibition. Dynamic neurotransmitter interactions in alcohol withdrawal

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2896%2991561-5

7 January 2021

Altered striatal dopamine re-uptake site densities in habitually violent and non-violent alcoholics.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2896%2991561-5

7 January 2021

Tiapride in the prevention of relapse in recently detoxified alcoholics

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2896%2991561-5

7 January 2021

Positron-emitting radioligands for studies in vivo-probes for human psychopharmacology

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2896%2991561-5

7 January 2021

Cocaine-induced reduction of glucose utilization in human brain. A study using positron emission tomography and [fluorine 18]-fluorodeoxyglucose.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2896%2991561-5

7 January 2021

Naltrexone in the treatment of alcohol dependence

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2896%2991561-5

7 January 2021

Blockade of delta-opioid receptors in the nucleus accumbens prevents ethanol-induced stimulation of dopamine release

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2896%2991561-5

7 January 2021

The effects of opioid peptides on dopamine release in the nucleus accumbens: an in vivo microdialysis study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2896%2991561-5

7 January 2021

Investigation of the opioid system in absence seizures with positron emission tomography.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2896%2991561-5

7 January 2021

Clonidine blocks acute opiate-withdrawal symptoms

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2896%2991561-5

7 January 2021

Central Norepinephrine Metabolism During Alcohol Intoxication in Addicts and Healthy Volunteers

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2896%2991561-5

7 January 2021

Noradrenergic dysregulation during discontinuation of cocaine use in addicts

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2896%2991561-5

7 January 2021

Differential role of mineralocorticoid and glucocorticoid receptors in the genesis of dexamphetamine-induced sensitization of mesolimbic, alpha 1 adrenergic receptors in the ventral striatum.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2896%2991561-5

7 January 2021

CSF biochemistries, glucose metabolism, and diurnal activity rhythms in alcoholic, violent offenders, fire setters, and healthy volunteers

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2896%2991561-5

7 January 2021

Ethanollike properties of the serotonergic partial agonist m-chlorophenylpiperazine in chronic alcoholic patients

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2896%2991561-5

7 January 2021

Selective reduction by the 5-HT antagonist amperozide of alcohol preference induced in rats by systemic cyanamide

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2896%2991561-5

7 January 2021

Buspirone Treatment of Anxious Alcoholics

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2896%2991561-5

7 January 2021

First delineation of 5-HT1A receptors in human brain with PET and [11C]WAY-100635

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2896%2991561-5

7 January 2021

Response to diazepam in sons of alcoholics

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2896%2991561-5

7 January 2021

https://api.crossref.org/works/10.1016%2FS0140-6736%2896%2991561-5

1 reference

7 January 2021

Inhibition of Morphine Tolerance and Dependence by the NMDA Receptor Antagonist MK-801

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2896%2991561-5

7 January 2021

Dynamic SPECT imaging after injection of the benzodiazepine receptor ligand [123I]iomazenil in healthy human subjects

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2896%2991561-5

7 January 2021

Anxiolytic effects of CCK-B antagonists

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2896%2991561-5

7 January 2021

Isolation and structure of a brain constituent that binds to the cannabinoid receptor

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2896%2991561-5

7 January 2021

SR141716A, a potent and selective antagonist of the brain cannabinoid receptor

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2896%2991561-5

7 January 2021

The role of neuronal calcium channels in dependence on ethanol and other sedatives/hypnotics

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2896%2991561-5

7 January 2021

10.1016/S0140-6736(96)91561-5

Identifiers

DOI

1 reference

24 September 2017

1 reference

PubMed ID

8531549